Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

Piper Sandler initiated coverage on Merus N.V. (NASDAQ:MRUS), a $2.8 billion market cap biotech company, with an Overweight rating and a price target of $84.00. According to InvestingPro data, the ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

Amos Cancer Center for treatment in November 2023. Transitioning into chemotherapy after her cancer diagnosis was difficult. I ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

文章摘要：■ III 期不可切除非小细胞肺癌患者治疗策略以根治性放化疗为主。然而在该治疗模式下，驱动基因阳性的 III 期患者治疗需求远远没有被满足。■ 免疫治疗和靶向治疗均是非小细胞肺癌治疗重要的研究与实践方向。对于原发性 MET 高拷贝数扩增合并 ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with KRAS+ non-small cell lung cancer as seen in clinical practice.

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...